Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
10.50
-0.60 (-5.41%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Rapport Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22
Market Capitalization
388649--
Enterprise Value
84330--
Last Close Price
10.6217.74--
Debt / Equity Ratio
0.010.010.050.54
Quick Ratio
34.8234.8216.7518.74
Current Ratio
35.3435.3417.1418.80
Return on Equity (ROE)
-35.09%-35.09%-43.36%-
Return on Assets (ROA)
-22.07%-22.07%-24.18%-
Return on Capital (ROIC)
-22.86%-22.86%-25.52%-
Buyback Yield / Dilution
-1277.25%-1277.25%-93.74%-
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q